• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙螯合剂对角膜通透性的影响。

Effects of calcium chelating agents on corneal permeability.

作者信息

Grass G M, Wood R W, Robinson J R

出版信息

Invest Ophthalmol Vis Sci. 1985 Jan;26(1):110-3.

PMID:3917988
Abstract

Corneal penetration studies have been conducted in unanesthetized albino rabbits using various organic compounds representing both polar and nonpolar species. In the presence of calcium chelating agents, polar compounds generally demonstrate an increase in corneal penetration. Evidence that this corneal effect is reversible is presented. Concomitant with an increase in both corneal and aqueous humor drug levels was a decrease in drug concentration in both iris and conjunctival tissues tentatively attributed to chelation effects on vascular permeability of these tissues. EDTA, a known calcium chelator, was shown to penetrate the cornea, conjunctiva, and iris/ciliary body from a topically applied dose. The implications of this observation pertain to both toxicity effects, when EDTA is incorporated into ocular drug products for stability purposes, and novel strategems for improving ocular bioavailability of topically applied drugs.

摘要

已使用代表极性和非极性物种的各种有机化合物,在未麻醉的白化兔身上进行了角膜渗透研究。在存在钙螯合剂的情况下,极性化合物通常表现出角膜渗透性增加。文中给出了这种角膜效应是可逆的证据。随着角膜和房水中药物水平的增加,虹膜和结膜组织中的药物浓度降低,这初步归因于螯合剂对这些组织血管通透性的影响。已知的钙螯合剂乙二胺四乙酸(EDTA)经局部给药后可穿透角膜、结膜和虹膜/睫状体。这一观察结果的意义既涉及将EDTA用于眼部药物产品以提高稳定性时的毒性影响,也涉及提高局部应用药物眼部生物利用度的新策略。

相似文献

1
Effects of calcium chelating agents on corneal permeability.钙螯合剂对角膜通透性的影响。
Invest Ophthalmol Vis Sci. 1985 Jan;26(1):110-3.
2
Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.角膜药物渗透机制。I:体内和体外动力学
J Pharm Sci. 1988 Jan;77(1):3-14. doi: 10.1002/jps.2600770103.
3
Mechanism of permeability-enhancing effect of EDTA and boric acid on the corneal penetration of 4-[1-hydroxy-1-methylethyl]-2-propyl-1-[4-[2-[tetrazole-5-yl]phenyl]phenyl] methylimidazole-5-carboxylic acid monohydrate (CS-088).
Int J Pharm. 2005 Aug 11;299(1-2):107-14. doi: 10.1016/j.ijpharm.2005.04.036.
4
Synergistic effect of EDTA and boric acid on corneal penetration of CS-088.乙二胺四乙酸(EDTA)和硼酸对CS-088角膜渗透的协同作用。
Int J Pharm. 2005 Feb 16;290(1-2):83-9. doi: 10.1016/j.ijpharm.2004.11.019. Epub 2005 Jan 13.
5
Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit.
J Pharmacol Exp Ther. 1988 Sep;246(3):871-8.
6
Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes.
Curr Eye Res. 1990 Nov;9(11):1051-9. doi: 10.3109/02713689008997579.
7
Effect of LTD4 on conjunctival vasopermeability and blood-aqueous barrier integrity.
Invest Ophthalmol Vis Sci. 1985 Apr;26(4):481-5.
8
[Amphotericin B--bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B].两性霉素B——在角膜中的生物利用度。脂质体包裹两性霉素B局部给药的研究
Ophthalmologe. 1995 Aug;92(4):469-75.
9
Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug.用于肽类药物眼部递送的含吸收促进剂的异硫氰酸荧光素标记葡聚糖的眼部通透性
J Drug Target. 1995;3(2):129-35. doi: 10.3109/10611869509059212.
10
Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea.壳聚糖、苯扎氯铵和乙二胺四乙酸对阿昔洛韦透过离体兔角膜的影响。
Int J Pharm. 2008 Feb 4;348(1-2):175-8. doi: 10.1016/j.ijpharm.2007.08.017. Epub 2007 Aug 19.

引用本文的文献

1
Topical Ocular Drug Delivery: The Impact of Permeation Enhancers.眼部局部给药:渗透促进剂的影响
Pharmaceutics. 2025 Mar 31;17(4):447. doi: 10.3390/pharmaceutics17040447.
2
Progress in Ocular Drug Delivery: Challenges and Constraints.眼部药物递送的进展:挑战与限制
Handb Exp Pharmacol. 2024;284:267-288. doi: 10.1007/164_2023_693.
3
Ocular safety of intravitreal ethylene diamine tetra acetic acid (EDTA): An experimental feasibility study.玻璃体内注射乙二胺四乙酸(EDTA)的眼部安全性:一项实验性可行性研究。
Toxicol Rep. 2023 Apr 6;10:463-468. doi: 10.1016/j.toxrep.2023.04.002. eCollection 2023.
4
Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs.溴莫尼定和噻吗洛尔局部给药后在兔体内的眼内及全身药代动力学:固定组合制剂与单一药物的比较
Ophthalmol Ther. 2020 Mar;9(1):115-125. doi: 10.1007/s40123-020-00229-x. Epub 2020 Jan 17.
5
Penetration Enhancers in Ocular Drug Delivery.眼部药物递送中的渗透促进剂
Pharmaceutics. 2019 Jul 9;11(7):321. doi: 10.3390/pharmaceutics11070321.
6
Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.靶向眼部药物递送:药代动力学/药效学考虑因素。
Pharm Res. 2018 Sep 25;35(11):217. doi: 10.1007/s11095-018-2498-y.
7
Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.眼部给药屏障——纳米载体在眼前节眼部疾病治疗中的作用
Pharmaceutics. 2018 Feb 27;10(1):28. doi: 10.3390/pharmaceutics10010028.
8
Sensitivity of Enzymatic Toxins from Corneal Isolate of Acanthamoeba Protozoan to Physicochemical Parameters.棘阿米巴原虫角膜分离株中酶毒素对物理化学参数的敏感性
Curr Microbiol. 2017 Nov;74(11):1316-1323. doi: 10.1007/s00284-017-1319-6. Epub 2017 Jul 28.
9
Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis.伏立康唑滴眼液治疗真菌性角膜炎的设计与评价
J Pharm (Cairo). 2014;2014:490595. doi: 10.1155/2014/490595. Epub 2014 Apr 29.
10
Enhancement in corneal permeability of riboflavin using calcium sequestering compounds.使用钙螯合化合物提高核黄素的角膜通透性。
Int J Pharm. 2014 Sep 10;472(1-2):56-64. doi: 10.1016/j.ijpharm.2014.06.007. Epub 2014 Jun 10.